Epigenetic therapies in heart failure

Area of Science:

• Cardiology
• Molecular Biology
• Genetics

Background:

• Heart failure (HF) is a leading cause of death with limited treatment options.
• Current therapies do not directly address the cellular state changes causing cardiac remodeling in HF.
• Stress-activated signaling pathways in HF influence nuclear gene control and cell state.

Purpose of the Study:

• To review the role of chromatin regulators in heart failure pathogenesis.
• To highlight specific proteins and RNA complexes as potential therapeutic targets in HF.
• To explore the link between cytosolic signaling and nuclear gene regulation in HF.

Main Methods:

• Literature review of current concepts in HF pathogenesis.
• Focus on chromatin regulatory apparatus and its role in cardiac remodeling.
• Identification of druggable targets within nuclear gene control machinery.

Main Results:

• Chromatin regulators are implicated in the molecular mechanisms of HF.
• Specific proteins and RNA complexes show therapeutic potential in experimental HF models.
• Understanding the coupling of signaling pathways to gene control is crucial for HF treatment.

Conclusions:

• Chromatin regulators represent a novel therapeutic avenue for heart failure.
• Targeting these nuclear components could overcome limitations of current pharmacotherapies.
• Further research into druggable targets may lead to improved HF management.